Moneycontrol PRO
Upcoming Webinar:Watch a panel of experts discuss: Challenges of continuously evolving regulation for Cryptocurrency, on 7th July at 3pm. Register Now
you are here: HomeNewsIndia

Mansukh Mandaviya to chair crucial meeting with experts on rising COVID-19 cases

India has been witnessing an increase in coronavirus infections over the last couple of weeks.

June 23, 2022 / 11:38 AM IST
Union Health Minister Mansukh Mandaviya

Union Health Minister Mansukh Mandaviya

Union Health Minister Mansukh Mandaviya will on Thursday chair a high-level review meeting with the core team of experts over increasing cases of COVID-19 in the country, official sources said. India has been witnessing an increase in coronavirus infections over the last couple of weeks.

As on date, ten states -- Maharashtra, Kerala, Delhi, Karnataka, Tamil Nadu, Haryana, Uttar Pradesh, Telangana, West Bengal and Gujarat -- have over 1,000 active cases. India saw a single-day rise of 13,313 new coronavirus infections, taking the infection tally to 4,33,44,958, while the active cases have increased to 83,990, according to the Union health ministry data updated on Thursday.

The death toll has climbed to 5,24,941 with 38 new fatalities, the data updated at 8 am stated. In a review meeting of INSACOG held last week, states/UTs were asked to submit "larger number" of samples for whole genome sequencing from districts and areas which have seen a surge in COVID-19 cases over a period of seven days.

In a review meeting of INSACOG held last week, states/UTs were asked to submit "larger number" of samples for whole genome sequencing from districts and areas which have seen a surge in COVID-19 cases over a period of seven days.

The direction was issued to check the possibility of any new emerging variant or sub-variant and ascertain the reasons behind the breakthrough infections, sources had said.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

According to the Indian SARS-CoV-2 Genomics Consortium (INSACOG) experts, Omicron and its sublineages, primarily BA. 2 and BA.2.38, as of now, seem to be behind the current rise in Covid cases, an official source had said.

The BA.2 and its sublineages constitute over 85 per cent of the cases with BA.2.38 being found in around 33 per cent of the samples. The percentage of BA.4 and BA.5 is found in less than 10 per cent samples, they had said.

Forty-three districts in India, including 11 from Kerala, six from Mizoram and five from Maharashtra, are reporting a weekly Covid positivity rate of more than 10 per cent. In 42 districts, including eight from Rajasthan, five from Delhi and four from Tamil Nadu, the weekly positivity is between 5 and 10 per cent, sources said.

(With PTI inputs)
Moneycontrol News
first published: Jun 23, 2022 11:40 am
Sections
ISO 27001 - BSI Assurance Mark